The NaBu Effect on Menstruation in Women

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Menstrual Symptoms
Interventions
DIETARY_SUPPLEMENT

Sodium Butyrate (NaBu)

Participants will self-administer Sodium Butyrate (NaBu) daily for 12 weeks. The study aims to evaluate the effect of NaBu on menstrual symptoms by comparing symptom severity before and during the intervention. Participants will maintain an electronic diary (eDiary) to record their daily symptom severity, which will be used to assess changes over time. Regular follow-ups will be conducted to monitor progress and address any side effects or concerns.

Trial Locations (1)

60611

RECRUITING

Northwestern University - Northwestern Medicine, Lavin Family Pavilion, Chicago

All Listed Sponsors
lead

Magdy Milad, MD

OTHER